Aravax: Future of Allergy Immunotherapy
Next generation food allergy treatment – it’s not just a question of efficacy By Pascal Hickey PhD, CEO, Aravax May 2026 Recent scientific and commercial developments in food allergy therapeutics are converging towards a common goal – transforming the outlook for patients and their families. It’s also clear the market is set to expand. SnackSafely.com […]

